Loading patent…
AssigneeArthroDynamic Technologies, Animal Health Division, Inc.
InventorFrank Marcum
Estimating the term…
The invention provides compositions and methods useful for the treatment and/or prevention of interstitial cystitis and/or a related urinary tract condition in man or in animals. Specifically, provided are compositions specially formulated for direct instillation into the bladder and/or parenteral use in the treatment and/or prevention of interstitial cystitis. Compositions adapted for direct instillation into the bladder and/or for systemic administration are provided comprised of therapeutic amounts of: chondroitin sulfate in combination with hyaluronan (hyaluronic acid) are provided. Compositions adapted for direct instillation into the bladder and/or for systemic administration are also provided comprised of therapeutic amounts of: chondroitin sulfate, hyaluronan (hyaluronic acid) and N-acetyl D-glucosamine.
A composition adapted for the treatment and/or prevention of interstitial cystitis or a related urinary tract condition in man or in animals, the composition comprising therapeutic amounts of chondroitin sulfate in combination with hyaluronan.
A composition adapted for the treatment and/or prevention of interstitial cystitis or a related urinary tract condition in man or in animals, the composition consisting essentially of therapeutic amounts of a combination of chondroitin sulfate and hyaluronan.
A method for the treatment and/or prevention of interstitial cystitis or a related urinary tract condition in man or in animals, comprising administering a therapeutic amount of a composition comprised of chondroitin sulfate in combination with hyaluronan.
A method for the treatment and/or prevention of interstitial cystitis or a related urinary tract condition in man or in animals, comprising administering a therapeutic amount of a composition consisting essentially of chondroitin sulfate in combination with hyaluronan.
A method for the treatment and/or prevention of interstitial cystitis or a related urinary tract condition in man or in animals, comprising administering a therapeutic amount of a composition consisting essentially of chondroitin sulfate, hyaluronan and N-acetyl D-glucosamine.
Dependencies are inferred from the claim text.